The manufacture and sale of products known as crib bumpers and sleep incliners — linked with more than 200 infant deaths in the United States — will be banned under a new law signed by President Joe Biden.
Researchers sought to evaluate the safety and efficacy of lower-sodium oxybate in adults with a primary diagnosis of idiopathic hypersomnia.
In order to evaluate the relationship of sleep disturbance to the antidepressant effects of esketamine, 2 double-blind, 4-week studies randomized adults with treatment-resistant depression (TRD) to placebo or esketamine nasal spray.
The researchers’ primary goal was to summarize existing evidence about daily associations between sleep and physical activity outcomes at inter- and intra-individual levels in adults.
With the use of sleep medication increasing, little is known about the long-term benefits of these medications. The researchers compared reductions in sleep difficulties across a large cohort of women who used and did not use prescription sleep medication.
Middle-aged women who initiate sleep medications do not have significant improvement in their sleep disturbance compared with those who do not initiate medications.
Sodium oxybate treatment may be associated with weight reduction and stabilization in children with type 1 narcolepsy.
In order to assess the efficacy and safety of JZP-258, a lower sodium alternative product to sodium oxybate, study authors designed a double-blind, placebo-controlled, randomized withdrawal, multicenter study with an open-label safety extension.
Individuals most at risk for neurobehavioral performance impairment during sleep deprivation can be accurately identified by a visual psychomotor vigilance task.
In patients with suspected or confirmed OSA, clinically significant erythrocytosis appears uncommon.
